Skip to main content
Fig. 9 | Stem Cell Research & Therapy

Fig. 9

From: A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats

Fig. 9

Histological results comparing bone lesions of NOVX rat femurs at 14 and 28 days after femoral surgery. CTR: (injury, control); heterologous fibrin sealant (HFS); heterologous fibrin sealant (HFS) + mesenchymal stem cells (MSCs); HFS + mesenchymal stem cells differentiated into the osteogenic lineage (MSCs D). Dotted circle: bone injury (hematoxylin and eosin). Bar: 500 μm, magnification: ×4

Back to article page